Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Tripep completes preclinical safety studies for alpha-HGA

Oct. 15, 2004

New anti-HIV agents in early development at Janssen

Oct. 15, 2004

Roche presents new anti-HIV reverse transcriptase inhibitors

Oct. 15, 2004

Merix Bioscience changes name to Argos Therapeutics, plans HIV study

Oct. 8, 2004

Another series of anti-HIV chemokine CCR5 antagonists presented by Takeda

Oct. 4, 2004

Two series of anti-HIV CCR5 antagonists reported by Takeda

Sep. 30, 2004

Lower infection rate found in some volunteers after receiving bivalent HIV vaccines

Sep. 28, 2004

Good safety profile reported for the NYVAC-HIVC vaccine in healthy volunteers

Sep. 27, 2004

GSK grants Kenyan company license for manufacture and sale of HIV/AIDS medicines in Africa

Sep. 27, 2004

Viral-specific immune responses induced with multiple-epitope vaccines for HIV-1 and SIV

Sep. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...